United States · Bill · HR
H.R. 2366 (117th)
STOP Fentanyl Act of 2021
Introduced
5 April 2021
Last action
19 October 2021 · Referred
Status
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Sponsors
Rep. Kuster, Ann M. [D-NH-2], Sen. Blunt Rochester, Lisa [D-DE], Rep. Deutch, Theodore E. [D-FL-22], Rep. Trone, David J. [D-MD-6], Rep. Ryan, Tim [D-OH-13], Rep. Tonko, Paul [D-NY-20], Rep. Dean, Madeleine [D-PA-4], Rep. Bacon, Don [R-NE-2], Rep. Morelle, Joseph D. [D-NY-25], Sen. Welch, Peter [D-VT], Rep. Dingell, Debbie [D-MI-6], Rep. Panetta, Jimmy [D-CA-19], Rep. Phillips, Dean [D-MN-3], Rep. Leger Fernandez, Teresa [D-NM-3]
Subjects
Healthcare
Source updated
20 January 2026
Summary
Support, Treatment, and Overdose Prevention of Fentanyl Act of 2021 or the STOP Fentanyl Act of 2021 This bill addresses data collection, treatment, harm reduction, and other issues related to substance misuse and addiction. It particularly focuses on opioids, fentanyl, and related substances. Specifically, the bill expands surveillance of fentanyl and related substances. This includes establishing a pilot program to screen for contaminants in illicit drugs and a grant program to collect data on fentanyl-involved overdoses. The bill also specifies requirements concerning the collection and use of information about drugs seized by law enforcement. Additionally, the bill establishes and modifies requirements to increase access to treatment and prevention services. For example, the Bureau of Prisons must make certain services, including medication-assisted treatments, available to individuals in its custody. The bill also repeals a provision that requires dependence on opioids for at least one year before an individual may be admitted to certain treatment programs; allows providers to prescribe medications to treat substance use disorders following a telehealth evaluation; creates grant programs for treatment and harm reduction activities; and addresses issues pertaining to opioid overdose reversal drugs. Furthermore, the bill limits civil and criminal liability under specified laws for individuals who administer opioid overdose reversal drugs to an individual who reasonably appears to be experiencing an overdose, as well as for individuals who seek medical attention for themselves or on behalf of another for a drug overdose. The bill also requires multiple reports, including a report by the Department of State on foreign sources of certain drugs.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
5 April 2021
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
5 April 2021
Introduced
Introduced in House
Source: IntroReferral
5 April 2021
Introduced
Introduced in House
Source: IntroReferral
13 April 2021
Referred
Referred to the Subcommittee on Health.
Source: Committee
19 October 2021
Referred
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 5 April 2021 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 5 April 2021
Introduced in House (PDF)
Introduced in House · EN · 5 April 2021
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 5 April 2021
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Kuster, Ann M. [D-NH-2] · D · Sponsor
- Sen. Blunt Rochester, Lisa [D-DE] · D · Sponsor
- Rep. Deutch, Theodore E. [D-FL-22] · D · Cosponsor
- Rep. Trone, David J. [D-MD-6] · D · Cosponsor
- Rep. Ryan, Tim [D-OH-13] · D · Cosponsor
- Rep. Tonko, Paul [D-NY-20] · D · Cosponsor
- Rep. Dean, Madeleine [D-PA-4] · D · Cosponsor
- Rep. Bacon, Don [R-NE-2] · R · Cosponsor
- Rep. Morelle, Joseph D. [D-NY-25] · D · Cosponsor
- Sen. Welch, Peter [D-VT] · D · Cosponsor
- Rep. Dingell, Debbie [D-MI-6] · D · Cosponsor
- Rep. Panetta, Jimmy [D-CA-19] · D · Cosponsor
- Rep. Phillips, Dean [D-MN-3] · D · Cosponsor
- Rep. Leger Fernandez, Teresa [D-NM-3] · D · Cosponsor
- · hsju00 · Standing
- · hsif00 · Standing
Related records
- related to ← STOP Fentanyl Act of 2021
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/2366
- Open data entity: https://api.congress.gov/v3/bill/117/hr/2366
- us · 117-hr-2366 · source updated 20 January 2026